Lv1
94 积分 2022-05-27 加入
Hypoxia-induced EGR1 remodels neutrophils to suppress antitumor immunity
1个月前
已完结
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
1个月前
已完结
PARP Inhibitors for Breast Cancer Treatment
2个月前
已完结
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial
2个月前
已完结
Nonestrogenic Management of Hot Flashes
2个月前
已完结
Clinical and biomarker predictors of side effects from tamoxifen
2个月前
已完结
Comparison of Menopausal Symptoms During the First Year of Adjuvant Therapy With Either Exemestane or Tamoxifen in Early Breast Cancer: Report of a Tamoxifen Exemestane Adjuvant Multicenter Trial Substudy
2个月前
已完结
Comparison of Menopausal Symptoms During the First Year of Adjuvant Therapy With Either Exemestane or Tamoxifen in Early Breast Cancer: Report of a Tamoxifen Exemestane Adjuvant Multicenter Trial Substudy
2个月前
已完结
Advances in the care of breast cancer survivors
2个月前
已完结
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause
2个月前
已完结
皖公网安备34019202002308
